Search results
Director, Center for Chemical Biology & Translational Medicine. Lieberman studies how certain viruses establish a long-term latent infection that can lead to cancer or autoimmune disorders. Lieberman joined The Wistar Institute in 1995 as an assistant professor.
Paul M. Lieberman is an American biomedical researcher and chairperson of the Gene Expression and Regulation Program at the Ellen and Ronald Caplan Cancer Center at The Wistar Institute in Philadelphia.
The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and …. PM Lieberman, JM...
Oct 28, 2021 · Research Interests. Genome maintenance and gene expression; Gammaherpesviruses and oncogenesis; Telomere Biology, Chromatin structure and genome stability; Transcription regulation. Key words: viral latency, telomeres, chromatin, DNA replication, transcription regulation, herpesvirus. Description of Research. Mechanisms of Genome Stability and ...
Jul 29, 2020 · Dr. Lieberman is a molecular virologist who leads a drug-discovery team at Wistar. He is repurposing existing drugs to target SARS-CoV-2 RNA pseudoknots, which are essential for viral replication and disease.
Paul M. Lieberman, Ph.D. Hillary Koprowski, M.D., Endowed Professor; Professor and Program Leader, Gene Expression and Regulation Program; Director, Center for Chemical Biology and Translational Medicine.
Professor, The Wistar Institute. Virology, Gene Expression, and Cancer. Viral Latency, Viral Genomics, Cancer Biology Projects relating to Epstein-Barr Virus, Kaposi's Sarcoma-Associated Herpesvirus, and Telomere Maintenance. Paul Lieberman. Biomedical Science. Penn CURF.
